L’avis intitulé « Vaccin antigrippal EFLUELDA : transition du vaccin antigrippal EFLUELDA, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
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
edB1GbeAgpW0JV5d
